Research Analysts’ Upgrades for December 14th (ACLS, AMSC, ARQT, CHA, COMP, EIX, ETR, EVMN, EVRG, EXEL)

Research Analysts’ upgrades for Sunday, December 14th:

Axcelis Technologies (NASDAQ:ACLS) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

American Superconductor (NASDAQ:AMSC) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Arcutis Biotherapeutics (NASDAQ:ARQT) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Chagee (NASDAQ:CHA) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Compass (NYSE:COMP) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Edison International (NYSE:EIX) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Entergy (NYSE:ETR) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Evommune (NYSE:EVMN) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Evergy (NASDAQ:EVRG) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Exelixis (NASDAQ:EXEL) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

First American Financial (NYSE:FAF) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Galapagos (NASDAQ:GLPG) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

INmune Bio (NASDAQ:INMB) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

IREN (NASDAQ:IREN) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Kinsale Capital Group (NYSE:KNSL) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Levi Strauss & Co. (NYSE:LEVI) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Macy’s (NYSE:M) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Monopar Therapeutics (NASDAQ:MNPR) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Nabors Industries (NYSE:NBR) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

NiSource (NYSE:NI) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Realty Income (NYSE:O) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Pentair (NYSE:PNR) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Personalis (NASDAQ:PSNL) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Arcus Biosciences (NYSE:RCUS) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Reddit (NYSE:RDDT) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Theravance Biopharma (NASDAQ:TBPH) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

TG Therapeutics (NASDAQ:TGTX) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Taiwan Semiconductor Manufacturing (NYSE:TSM) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Western Midstream Partners (NYSE:WES) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.